TABLE 3.
Mean estimates ± SE (95% CI) for participant-reported outcomes (n = 22).
| Outcome | Baseline | Preoperative | 6-weeks postoperative assessment | 12-weeks postoperative assessment |
| GLTEQ | 22.8 ± 5.30 (11.91, 33.7) | 37.9 ± 6.10 (25.53, 50.3) | 21.7 ± 6.31 (8.92, 34.5) | 33.8 ± 6.12 (21.38, 46.2) |
| WHODAS: Average Disability Score | 30.0 ± 2.34 (25.1, 34.8) | 29.2 ± 2.57 (23.9, 34.5) | 33.2 ± 2.69 (27.7, 38.7) | 30.2 ± 2.63 (24.8, 35.5) |
| FACT-F | 37.9 ± 2.54 (32.7, 43.1) | 39.7 ± 3.02 (33.6, 45.8) | 36.0 ± 3.26 (29.4, 42.6) | 33.3 ± 3.13 (26.9, 39.6) |
| BPI: Severity | 1.63 ± 0.36 (0.89, 2.36) | 2.03 ± 0.40 (1.21, 2.84) | 1.72 ± 0.42 (0.86, 2.58) | 1.82 ± 0.41 (0.98, 2.66) |
| BPI: Interference | 1.33 ± 0.48 (0.34, 2.33) | 1.48 ± 0.53 (0.39, 2.58) | 2.18 ± 0.56 (1.04, 3.32) | 1.54 ± 0.55 (0.42, 2.65) |
| DASH | 8.99 ± 3.54 (1.73, 16.2) | 11.97 ± 4.28 (3.31, 20.6) | 28.16 ± 4.44 (19.19, 37.1) | 20.96 ± 4.28 (12.28, 29.6) |
| SF-36: PCS | 35.50 ± 1.46 (32.6, 38.5) | 33.70 ± 1.79 (30.1, 37.4) | 30.50 ± 1.95 (26.6, 34.5) | 29.60 ± 1.86 (25.9, 33.4) |
| SF-36: MCS | 43.00 ± 1.70 (39.5, 46.5) | 41.20 ± 1.96 (37.2, 45.2) | 45.60 ± 2.09 (41.3, 49.8) | 44.90 ± 2.02 (40.8, 49.0) |
GLTEQ, Godin Leisure Time Exercise Questionnaire; WHODAS, World Health Organization Disability Assessment Schedule; FACT-F, functional assessment of cancer therapy—fatigue; BPI, brief pain inventory; DASH, disabilities of arm, shoulder, and hand; SF-36 PCS, 36 item short form survey physical component score; SF-36 MCS, 36 item short form survey mental component score.